Health2023 saw a cautious hope for Alzheimer's treatment but doubts remain The US approved lecanemab to slow cognitive decline among people with early Alzheimer's, but not everyone is convinced the drug has that big of an impact – not to mention concerns over its safety and practicality ¿ìè¶ÌÊÓÆµ
HealthVegans who avoid ultra-processed food risk being protein deficient Two relatively recent dietary trends – veganism and concerns about highly processed foods – may be in conflict with each other ¿ìè¶ÌÊÓÆµ